- Home
- KYMR vs REZI Comparison
KYMR vs REZI Comparison
Compare KYMR & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- REZI
- Stock Information
- Founded
- KYMR 2015
- REZI 2018
- Country
- KYMR United States
- REZI United States
- Employees
- KYMR N/A
- REZI N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- REZI Wholesale Distributors
- Sector
- KYMR Health Care
- REZI Industrials
- Exchange
- KYMR Nasdaq
- REZI Nasdaq
- Market Cap
- KYMR 3.1B
- REZI 3.1B
- IPO Year
- KYMR 2020
- REZI N/A
- Fundamental
- Price
- KYMR $44.64
- REZI $23.85
- Analyst Decision
- KYMR Strong Buy
- REZI Hold
- Analyst Count
- KYMR 16
- REZI 1
- Target Price
- KYMR $58.94
- REZI $21.00
- AVG Volume (30 Days)
- KYMR 865.2K
- REZI 1.2M
- Earning Date
- KYMR 08-06-2025
- REZI 08-07-2025
- Dividend Yield
- KYMR N/A
- REZI N/A
- EPS Growth
- KYMR N/A
- REZI N/A
- EPS
- KYMR N/A
- REZI 0.30
- Revenue
- KYMR $58,885,000.00
- REZI $7,045,000,000.00
- Revenue This Year
- KYMR $58.26
- REZI $11.43
- Revenue Next Year
- KYMR N/A
- REZI $3.45
- P/E Ratio
- KYMR N/A
- REZI $78.56
- Revenue Growth
- KYMR N/A
- REZI 14.02
- 52 Week Low
- KYMR $19.45
- REZI $14.18
- 52 Week High
- KYMR $53.27
- REZI $28.28
- Technical
- Relative Strength Index (RSI)
- KYMR 55.84
- REZI 66.25
- Support Level
- KYMR $43.56
- REZI $23.12
- Resistance Level
- KYMR $46.34
- REZI $24.62
- Average True Range (ATR)
- KYMR 1.81
- REZI 0.64
- MACD
- KYMR -0.60
- REZI 0.08
- Stochastic Oscillator
- KYMR 36.21
- REZI 78.29
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.